Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery

European Journal of Pharmacology

Volumn 406, Issue 1, 2000, Pages 117-122

  White, Linda R ^a   Juul, Roar ^a   Skaanes, Karl O ^a   Aasly, Jan ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokine; Endothelin ET(B) receptor; Interferon ; Interleukin 1 ; Interleukin 6; Sarafotoxin S6c; TNF (tumour necrosis factor ); Vasoactivity

Indexed keywords

CYTOKINE; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; SARAFOTOXIN; SARAFOTOXIN S6C; TUMOR NECROSIS FACTOR ALPHA;

ARTERY CONSTRICTION; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; ENCEPHALITIS; HUMAN; HUMAN TISSUE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TEMPORAL ARTERY;

CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIN-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; TEMPORAL ARTERIES; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VIPER VENOMS;

EID: 0034613205     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00642-7     Document Type: Article

References (35)

1. Adner M., Cantera L., Ehlert F., Nilsson L., Edvinsson L. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br. J. Pharmacol. 119:1996;1159-1166.
2. Adner M., Uddman E., Cardell L.O., Edvinsson L. Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture. Cardiovasc. Res. 37:1998;254-262.
3. Bavbek M., Polin R., Kwan A.L., Arthur A.S., Kassell N.F., Lee K.S. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke. 29:1998;1930-1935.
4. Eder J. Tumour necrosis factor α and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol. Sci. 18:1997;319-322.
5. Garcia J.H., Liu K.-F., Relton J.K. Interleukin-1 receptor antagonist decreases the number of neurotic neurons in rats with middle-cerebral artery occlusion. Am. J. Pathol. 137:1995;1477-1486.
6. Heremans H., Dillen C., Dijkmans R., Grau G., Billiau A. The role of cytokines in various models of inflammation. Lymphokine Res. 8:1989;329-333.
7. Hino A., Tokuyama Y., Kobayashi M., Yano M., Weir B., Takeda J., Wang X., Bell G.I., Macdonald R.L. Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J. Cereb. Blood Flow Metab. 16:1996;688-697.
8. Högestätt E.D., Andersson K.-E., Edvinsson L. Mechanical properties of rat arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol. Scand. 117:1983;49-61.
9. Hohlfeld T., Klemm P., Thiemermann C., Warner T.D., Schrör K., Vane J.R. The contribution of tumour necrosis factor-α and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br. J. Pharmacol. 116:1995;3309-3315.
10. Kim J.S. Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci. 137:1996;69-78.
11. B receptor contractile activity in rat cerebral artery. NeuroReport. 10:1999;2355-2359.
12. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:1998;176-179.
13. B receptors. Peptides. 17:1996;1139-1144.
14. B receptors after organ culture. Eur. J. Pharmacol. 329:1997;69-77.
15. Patel T.R., Galbraith S., Graham D.I., Hallak H., Doherty A.M., McCulloch J. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J. Cereb. Blood Flow Metab. 16:1996;950-958.
16. Patel T.R., Galbraith S., McAuley M.A., McCulloch J. Endothelin-mediated vascular tone following focal cerebral ischaemia in the cat. J. Cereb. Blood Flow Metab. 16:1996;679-687.
17. Pierre L.N., Davenport A.P. Autoradiographic study of endothelin receptors in human cerebral arteries. J. Cardiovasc. Pharmacol. 26(Suppl. 3):1995;S326-S328.
18. Pierre L.N., Davenport A.P. Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain. J. Cardiovasc. Pharmacol. 31(Suppl. 1):1998;S74-S76.
19. Pittet J.F., Morel D.R., Hemsen A., Gunning K., Lacroix J.-S., Suter P.M., Lundberg J.M. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg. 213:1991;261-264.
20. Pluta R.M., Boock R.J., Afshar J.K., Clouse K., Bacic M., Ehrenreich H., Oldfield E.H. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J. Neurosurg. 87:1997;287-293.
21. Roux S., Löffler B.-M., Gray G.A., Sprecher U., Clozel M., Clozel J.-P. The role of endothelin in experimental cerebral vasospasm. Neurosurgery. 37:1995;78-86.
22. Ruetten H., Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J. Physiol. Pharmacol. 48:1997;675-688.
23. Sharma R., Coats A.J.S., Anker S.D. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int. J. Cardiol. 72:2000;175-186.
24. Touzani O., Galbraith S., Siegl P., McCulloch J. Endothelin-B receptors in cerebral resistance arterioles and their functional significance after focal cerebral ischemia in cats. J. Cereb. Blood Flow Metab. 17:1997;1157-1165.
25. B receptor-mediated contraction. Eur. J. Pharmacol. 376:1999;223-232.
26. Van Deuren M., Van der Ven-Jongekrijg J., Bartelink A.K., Van Dalen R., Sauerwein R.W., Van der Meer J.W. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172:1995;433-439.
27. Wanebo J.E., Arthur A.S., Louis H.G., West K., Kassell N.F., Lee K.S., Helm G.A. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery. 43:1998;1409-1418.
28. B contractile activity in cultured segments of human temporal artery. Acta Physiol. Scand. 164:1998;21-27.
29. B receptor-mediated contraction in cultured segments of human temporal artery. Regul. Pept. 81:1999;89-95.
30. Williams D.L. Jr., Jones K.L., Pettibone D.J., Lis E.V., Clineschmidt B.V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 175:1991;556-561.
31. Woods M., Mitchell J.A., Wood E.G., Barker S., Walcot N.R., Rees G.M., Warner T.D. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol. Pharmacol. 55:1999;902-909.
32. Yoshizumi M., Kurihara H., Morita T., Yamashita T., Oh-hashi Y., Sugiyama T., Takaku F., Yanagisawa M., Masaki T., Yazaki Y. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem. Biophys. Res. Commun. 166:1990;324-329.
33. Zimmermann M., Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery. 43:1998;863-876.
34. B receptors in subarachnoid hemorrhage-induced cerebral vasospasm. Eur. J. Pharmacol. 259:1994;R1-R2.
35. Zuccarello M., Boccaletti R., Romano A., Rapoport R.M. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke. 29:1998;1924-1929.